Articles By Jack Cush, MD
Adherence to Hydroxychloroquine Lowers Lupus Mortality
By Jack Cush, MD
07 January 2021
A lupus cohort study from British Columbia, Canada has shown that medication adherence with hydroxychloroquine (HCQ) is associated with a 71% to 83% lower mortality.
Read Article
Rhapsody Study: IL-1 Inhibition in Recurrent Pericarditis
By Jack Cush, MD
06 January 2021
Recurrent pericarditis is a rare, probable autoinflammatory disorder mediated by interleukin-1 (IL-1); and is often refractory to glucocorticoids and colchicine.
Read Article
EULAR Guidance on Patient Adherence to Meds
By Jack Cush, MD
06 January 2021
Non-adherence may be the single most untold risk to suboptimal outcomes in the care of musculoskeletal disease. It has been estimated that 30-80% of patients with rheumatic and musculoskeletal diseases (RMDs) are nonadherent to prescribed regimens. EULAR has commissioned a task force to study t
Read Article
Zoomatology – Present in Absentia
By Jack Cush, MD
06 January 2021
Are you a zoomatologist or a doomsatologist? Zoom has replaced the meeting, the teleconference or the board meeting. If your old meetings were bad, then your replacement zoom meetings will also be bad, if not worse. Largely because you have failed to master the medium. Here are the new rules of Zoom.
Read Article
20,21 Whatever it Takes
By Jack Cush, MD
05 January 2021
Amazingly, we made it through 2020, a most forgettable year. Life was great in the first 3 months of 2020, and then COVID hit the fan and a pandemic steamroller derailed life as we knew it.
Read Article
COVID-19 Vaccination - Phase Ib Begins
By Jack Cush, MD
04 January 2021
The U.S. Centers for Disease Control and Prevention (CDC) has issued a timeline guidance document on when, how and who should get the commercially available COVID-19 vaccines.
Read Article
Telemedicine Less Utilized in the South and Urban Areas
By Jack Cush, MD
04 January 2021
MMWR has reported on a July 2020 survey study from 1,009 Health Resources and Services Administration–funded health centers showing that urban Health centers were more likely to provide virtual visits than those in rural areas.
Read Article
Plaquenil Does Not Protect Lupus Patients from COVID-19 (Best of 2020)
By Jack Cush, MD
31 December 2020
Annals of Rheumatic Disease reports on an analysis of lupus (SLE) patients that shows COVID-19 infection rates were similar between those lupus patients who were taking hydroxychloroquine (HCQ) and those not taking HCQ.
Read Article
Update on Polymyalgia Rheumatica and Giant Cell Arteritis (Best of 2020)
By Jack Cush, MD
31 December 2020
JAMA has published a clinical update of recent studies on GCA. While PET/CT scanning are novel means of demonstrating activity, they have not changed the diagnostic approach to GCA or PMR and although there are no new proven treatment strategies for PMR beyond glucocorticoids, the FDA has approved tocilizumab as a first-line glucocorticoid-sparing agent.
Read Article
ACR 2020 Reproductive Guidelines - Medication Use with Pregnancy (Best of 2020)
By Jack Cush, MD
30 December 2020
The ACR has published guidelines to manage reproductive health issues in rheumatic disease (RMD) patients before, during and after pregnancy. In this second excerpt from their guidelines articles, we present recommendations (and good clinical practice statements) for paternal rheumatology medication use by men with RMD and on conventional rheumatology medications and biologic use in pregnancy for women with RMD.
Read Article